NCT07283731
- Conditions
- Advanced/Metastatic, Neoplasm Metastasis, Neoplasms, +10 more
- Locations
-
- MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Pembrolizumab
Explore clinical trials studying Pembrolizumab. Study availability and eligibility vary by location and protocol.
7 public trials
4 recruiting studies
Pembrolizumab trial results
NCT07261683
- Conditions
- Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +15 more
- Locations
-
- Obstetrics and Gynecology Hospital of Fudan University Shanghai, Shanghai Municipality, China
NCT06389422
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciecnces and Peking Union Medical College Beijing, Beijing Municipality, China
NCT06102395
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more
- Locations
-
- Beijing Tongren Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Neoadjuvant Immunotherapy and Organ-sparing Treatment in Patients With Stage I-III dMMR Colon Cancer
NCT07409844
- Conditions
- Colon Cancer Stage I, Colon Cancer Stage II/III, Colonic Diseases, +13 more
- Locations
-
- Zealand University Hospital Køge, Denmark
Not Yet Recruiting
Phase Ib/II Trial of Combining Pembrolizumab and Lenvatinib With SBRT for HCC Patients With Portal Vein Thrombosis.
NCT05286320
- Conditions
- Lenvatinib, Pembrolizumab, Stereotactic Body Radiotherapy, +1 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiawn, Taiwan
NCT07233759
- Conditions
- Atezolizumab, Digestive System Diseases, Digestive System Neoplasms, +7 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan